Table 3.
Characteristics | OS | BCSS | |||||||
---|---|---|---|---|---|---|---|---|---|
95% CI | 95% CI | ||||||||
HR | Low | High | P | HR | Low | High | P | ||
Race | |||||||||
White | Reference | Reference | |||||||
Black | 1.312 | 1.197 | 1.438 | <0.001 | 1.174 | 1.029 | 1.339 | 0.017 | |
Other | 0.696 | 0.611 | 0.793 | <0.001 | 0.743 | 0.617 | 0.894 | 0.002 | |
Age | |||||||||
<50 | Reference | Reference | |||||||
50≤;<70 | 1.531 | 1.363 | 1.72 | <0.001 | 1.179 | 1.024 | 1.358 | 0.022 | |
≥70 | 4.048 | 3.606 | 4.544 | <0.001 | 2.37 | 2.045 | 2.748 | <0.001 | |
Grade | |||||||||
I | Reference | Reference | |||||||
II | 1.161 | 1.042 | 1.293 | 0.007 | 1.768 | 1.385 | 2.257 | <0.001 | |
III | 1.595 | 1.412 | 1.802 | <0.001 | 2.974 | 2.313 | 3.824 | <0.001 | |
Subtype | |||||||||
HR+/Her2- | Reference | Reference | |||||||
HR+/Her2+ | 0.987 | 0.866 | 1.126 | 0.848 | 0.781 | 0.634 | 0.962 | 0.02 | |
HR-/Her2+ | 1.152 | 0.984 | 1.348 | 0.078 | 1.013 | 0.816 | 1.256 | 0.91 | |
HR-/Her2- | 1.444 | 1.312 | 1.59 | <0.001 | 1.555 | 1.371 | 1.764 | <0.001 | |
Stage | |||||||||
I | Reference | Reference | |||||||
II | 2.472 | 2.241 | 2.727 | <0.001 | 4.366 | 3.714 | 5.133 | <0.001 | |
III | 7.348 | 6.683 | 8.078 | <0.001 | 17.644 | 15.16 | 20.536 | <0.001 | |
Radiation | |||||||||
No | Reference | Reference | |||||||
Yes | 0.341 | 0.317 | 0.367 | <0.001 | 0.366 | 0.329 | 0.407 | <0.001 | |
Chemotherapy | |||||||||
No | Reference | Reference | |||||||
Yes | 0.773 | 0.708 | 0.844 | <0.001 | 0.935 | 0.822 | 1.063 | 0.305 | |
Year of diagnosis | |||||||||
2020 | Reference | Reference | |||||||
2018 | 0.861 | 0.743 | 0.996 | 0.045 | 1.001 | 0.791 | 1.267 | 0.994 | |
2019 | 0.887 | 0.766 | 1.026 | 0.105 | 0.998 | 0.789 | 1.262 | 0.985 |